TRICIDA, INC.

TCDA NASDAQ
33.67
+0.30
+0.90%
After Hours: 33.67 0 0.00% 17:53 07/17 EDT
Open
33.50
Prev Close
33.37
High
34.21
Low
32.86
Volume
104.75K
Avg Vol (3M)
248.60K
52 Week High
42.80
52 Week Low
19.43
% Turnover
0.27%
Market Cap
1.31B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers TRICIDA, INC. TCDA stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Tricida, Inc. is a late-stage pharmaceutical company focused on the discovery and clinical development of non-absorbed therapeutics to address renal, metabolic and cardiovascular disease. The Company's lead program, TRC101 is a treatment for chronic kidney disease (CKD). The Company is engaged in developing a non-absorbed drug to enable safety and efficacy for chronic treatment of CKD patients. The TRC101 drug acts in the gastrointestinal tract and clears the human body through the digestive system, by preventing degradation and systemic uptake.
MORE >

Recently

Name
Price
%Change